secwatch.observer — SEC 8-K summary
======================================

Issuer:     CYTOKINETICS INC (CYTK)
CIK:        0001061983
Form:       8-K
Filed at:   2026-05-27T20:00:58+00:00
Accession:  0001193125-26-241840
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Cytokinetics shareholders re-elect three Class I directors and approve all four proposals at annual meeting
--------------------------------------------------------------------------------

- Edward M. Kaye, Wendell Wierenga, and Nancy J. Wysenski re-elected as Class I directors; Wierenga received 85.4M for vs 22.4M withheld.
- ESPP amendment approved to increase authorized shares by 1,000,000; 107.3M for, 261k against.
- Ernst & Young LLP ratified as auditor for FY 2026; 115.5M for, 269k against.
- Advisory vote on executive compensation passed with 104.0M for, 3.0M against.
- Quorum of 93.47% of eligible shares represented at meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1061983/000119312526241840/0001193125-26-241840-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1061983/000119312526241840/cytk-20260527.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-241840

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer